BRPI0402630B8 - processo de obtenção de vacina pertussis celular menos reatogênica - Google Patents

processo de obtenção de vacina pertussis celular menos reatogênica

Info

Publication number
BRPI0402630B8
BRPI0402630B8 BRPI0402630A BRPI0402630A BRPI0402630B8 BR PI0402630 B8 BRPI0402630 B8 BR PI0402630B8 BR PI0402630 A BRPI0402630 A BR PI0402630A BR PI0402630 A BRPI0402630 A BR PI0402630A BR PI0402630 B8 BRPI0402630 B8 BR PI0402630B8
Authority
BR
Brazil
Prior art keywords
obtaining
pertussis vaccine
cellular pertussis
less reactogenic
vaccine
Prior art date
Application number
BRPI0402630A
Other languages
English (en)
Inventor
Silvina Piccini Quintas Horton Denise
Leme Ednilse
Mendes Elizabeth
Saldanha Kubrusly Flávia
Gondo Higashi Hisako
Raw Isaias
Aparecida Sakauchi Maria
Izabel Esteves Maria
Furuyama Noemi
Müller Affonso Prado Sally
Quintilio Wagner
De Oliveira Dias Waldely
Original Assignee
Fund Butantan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund Butantan filed Critical Fund Butantan
Priority to BRPI0402630A priority Critical patent/BRPI0402630B8/pt
Priority to PCT/BR2004/000172 priority patent/WO2006002502A1/en
Priority to EP04761533A priority patent/EP1809323A1/en
Publication of BRPI0402630A publication Critical patent/BRPI0402630A/pt
Publication of BRPI0402630B1 publication Critical patent/BRPI0402630B1/pt
Publication of BRPI0402630B8 publication Critical patent/BRPI0402630B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

processo de obtenção de nova vacina pertussis celular, que prevê a utilização de células de bordetella pertussis, obtidas por cultivo em fermentador, destoxificadas por formaldeído, que após tratamento com solvente orgânico originam preparações vacinais menos tóxicas e tão potentes quanto a vacina pertussis celular tradicional.
BRPI0402630A 2004-07-05 2004-07-05 processo de obtenção de vacina pertussis celular menos reatogênica BRPI0402630B8 (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0402630A BRPI0402630B8 (pt) 2004-07-05 2004-07-05 processo de obtenção de vacina pertussis celular menos reatogênica
PCT/BR2004/000172 WO2006002502A1 (en) 2004-07-05 2004-09-13 Process for obtention of new cellular pertussis vaccine
EP04761533A EP1809323A1 (en) 2004-07-05 2004-09-13 Process for obtention of new cellular pertussis vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0402630A BRPI0402630B8 (pt) 2004-07-05 2004-07-05 processo de obtenção de vacina pertussis celular menos reatogênica

Publications (3)

Publication Number Publication Date
BRPI0402630A BRPI0402630A (pt) 2006-08-01
BRPI0402630B1 BRPI0402630B1 (pt) 2019-12-10
BRPI0402630B8 true BRPI0402630B8 (pt) 2021-05-25

Family

ID=36716698

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0402630A BRPI0402630B8 (pt) 2004-07-05 2004-07-05 processo de obtenção de vacina pertussis celular menos reatogênica

Country Status (3)

Country Link
EP (1) EP1809323A1 (pt)
BR (1) BRPI0402630B8 (pt)
WO (1) WO2006002502A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1003753B1 (pt) * 2010-09-28 2020-07-28 Fundação Butantan composições imunogênicas sinérgicas baseadas em antígenos protéicos combinados com antígeno celular pertussis e toxinas inativadas
SG11201500573RA (en) 2012-08-06 2015-02-27 Glaxosmithkline Biolog Sa Method for eliciting in infants an immune response against rsv and b. pertussis
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2014304545A1 (en) 2013-08-05 2016-02-25 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
EP4169513A1 (en) 2021-10-19 2023-04-26 GlaxoSmithKline Biologicals S.A. Adjuvant composition comprising sting agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
ATE127347T1 (de) * 1989-04-28 1995-09-15 Sclavo Spa Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.

Also Published As

Publication number Publication date
BRPI0402630B1 (pt) 2019-12-10
WO2006002502A1 (en) 2006-01-12
EP1809323A1 (en) 2007-07-25
BRPI0402630A (pt) 2006-08-01

Similar Documents

Publication Publication Date Title
CL2020002805A1 (es) Método para identificar un modulador de un sistema biológico; método para identificar un modulador de un proceso de enfermedad (divisional 201302526)
DK1603663T3 (da) Keramisk nanofiltrationsmembran til anvendelse i organiske opløsningsmidler og fremgangsmåde til deres fremstilling
PA8629901A1 (es) Sintesis regioespecifica de derivados de 42-ester de rapamicina
MX2007003378A (es) Control de parasitos en animales mediante el uso de nuevos derivados de trifluorometansulfonanilida oxima eter.
BRPI0516389A (pt) processo para formar um artigo tridimensional conformado e aparelho
BRPI0517238A (pt) formulações que compreendem ecteinascidina e um dissacarìdeo
CL2009000853A1 (es) Composicion para tratar un fluido con contaminantes que comprende un compuesto insoluble que contiene tierras raras y un ligante polimerico; proceso para preparar la composicion mezclando los componentes y somenterlos a tratamiento mecanico, quimico termico para adherir el compuesto insoluble al ligante.
UY29149A1 (es) Tiazolil-dihidro-indazoles
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112013024965A2 (pt) composto, composição farmacêutica, método de tratamento de infecções virais, e, processo para preparar um composto
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
BRPI0402630A (pt) processo de obtenção de nova vacina pertussis celular
CL2008003820A1 (es) Metodo para producir el virus de estomatitis vesicular atenuado (vsv) en un cultivo celular que comprende introducir en un vector el gen vsv g optimizado; composicion inmunogenica que comprende el vsv atenuado; kit para producir el vsv.
ATE512931T1 (de) Verfahren zur herstellung von ammoniumheptamolybdat
ATE504554T1 (de) Verfahren zur substitution von indenofluorenen
TW200507867A (en) Extract of plant dendrobii caulis and preparing process thereof
CN106967666B (zh) 一种在水中利用尿素大量诱导少孢节丛孢产捕器的方法
AR051144A1 (es) Procedimiento para formar atorvastatina amorfa
AR065847A1 (es) Composicion portadora de rapida accion para la insercion de acido nucleico. metodo. uso.
MX336067B (es) Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma.
BRPI0416274A (pt) método para produzir solução de amÈnio de ácido orgánico
AR014528A1 (es) Adn que comprende una secuencia de nucleotidos que se puede traducir a una proteina con actividad de invertasa, proteina derivada del adn que tieneactividad de invertasa pero que carece de actividad beta-fructofuranosidasa; metodo para producir adn y dicho metodo donde el adn es producido por una
UY29498A1 (es) Derivados de aminoácidos
ES2530760T3 (es) Peptidasas de basidiomicetos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/12/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/12/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/07/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2677 DE 26-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.